Citadel Advisors’s Octave Specialty Group OSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$352K Sell
75,600
-1,252,400
-94% -$7.17M ﹤0.01% 10115
2025
Q4
$10.3M Buy
1,328,000
+297,100
+29% +$2.54M ﹤0.01% 3215
2025
Q3
$8.6M Buy
1,030,900
+873,200
+554% +$7.38M ﹤0.01% 3489
2025
Q2
$1.12M Sell
157,700
-137,100
-47% -$1.02M ﹤0.01% 6845
2025
Q1
$2.58M Buy
294,800
+68,500
+30% +$721K ﹤0.01% 5044
2024
Q4
$2.86M Sell
226,300
-37,300
-14% -$450K ﹤0.01% 4919
2024
Q3
$2.95M Buy
263,600
+143,300
+119% +$1.68M ﹤0.01% 4811
2024
Q2
$1.54M Sell
120,300
-27,600
-19% -$421K ﹤0.01% 5795
2024
Q1
$2.31M Sell
147,900
-19,900
-12% -$314K ﹤0.01% 5240
2023
Q4
$2.77M Buy
167,800
+101,200
+152% +$1.41M ﹤0.01% 4791
2023
Q3
$803K Buy
66,600
+23,400
+54% +$314K ﹤0.01% 7029
2023
Q2
$615K Sell
43,200
-131,500
-75% -$1.92M ﹤0.01% 7478
2023
Q1
$2.7M Buy
174,700
+69,700
+66% +$1.13M ﹤0.01% 4810
2022
Q4
$1.83M Sell
105,000
-309,800
-75% -$4.6M ﹤0.01% 5642
2022
Q3
$5.29M Buy
414,800
+325,500
+365% +$4.34M ﹤0.01% 3765
2022
Q2
$1.01M Sell
89,300
-188,200
-68% -$1.79M ﹤0.01% 6987
2022
Q1
$2.89M Buy
277,500
+168,400
+154% +$2.28M ﹤0.01% 5283
2021
Q4
$1.75M Buy
109,100
+48,300
+79% +$759K ﹤0.01% 6555
2021
Q3
$871K Buy
60,800
+3,200
+6% +$45.7K ﹤0.01% 8493
2021
Q2
$902K Buy
57,600
+8,100
+16% +$130K ﹤0.01% 8623
2021
Q1
$829K Sell
49,500
-3,600
-7% -$58.8K ﹤0.01% 8563
2020
Q4
$817K Buy
53,100
+4,100
+8% +$60.4K ﹤0.01% 7216
2020
Q3
$626K Sell
49,000
-97,900
-67% -$1.26M ﹤0.01% 6877
2020
Q2
$2.1M Sell
146,900
-76,700
-34% -$1.12M ﹤0.01% 4481
2020
Q1
$2.76M Buy
223,600
+168,300
+304% +$3.23M ﹤0.01% 3603
2019
Q4
$1.19M Sell
55,300
-17,600
-24% -$361K ﹤0.01% 5279
2019
Q3
$1.43M Sell
72,900
-1,276,800
-95% -$23.4M ﹤0.01% 5012
2019
Q2
$22.7M Buy
1,349,700
+901,500
+201% +$15.4M 0.01% 1309
2019
Q1
$8.12M Buy
448,200
+369,900
+472% +$7.07M ﹤0.01% 2321
2018
Q4
$1.35M Buy
78,300
+8,200
+12% +$151K ﹤0.01% 4804
2018
Q3
$1.43M Buy
70,100
+22,400
+47% +$468K ﹤0.01% 4937
2018
Q2
$947K Buy
47,700
+18,200
+62% +$336K ﹤0.01% 5316
2018
Q1
$463K Buy
+29,500
New +$456K ﹤0.01% 6005
2017
Q4
Sell
-11,200
Closed -$193K 7920
2017
Q3
$193K Buy
11,200
+100
+0.9% +$1.85K ﹤0.01% 6725
2017
Q2
$193K Sell
11,100
-40,100
-78% -$712K ﹤0.01% 6598
2017
Q1
$966K Buy
51,200
+26,200
+105% +$551K ﹤0.01% 4048
2016
Q4
$563K Buy
25,000
+12,400
+98% +$271K ﹤0.01% 4715
2016
Q3
$232K Buy
+12,600
New +$226K ﹤0.01% 6094

Other funds holding OSG

Citadel Advisors's OSG Position: Q1 2026 in Review

Citadel Advisors increased its Octave Specialty Group (OSG) stake by 50% in Q1 2026, buying an estimated $827K and bringing the position to 431,809 shares worth $2.01M. The position accounts for ﹤0.01% of the portfolio, ranked #6057.

Citadel Advisors first reported a position in OSG in Q2 2013 and has held it in 48 quarters since. The position peaked at $9.65M in Q1 2025. 148 funds tracked by Wall St. Rank hold OSG as of Q1 2026.

  • Citadel Advisors held 431,809 shares of Octave Specialty Group worth $2.01M as of Q1 2026.
  • Citadel Advisors bought 144,526 Octave Specialty Group shares in Q1 2026, an estimated $827K.
  • Octave Specialty Group made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6057 holding.
  • Citadel Advisors first reported a position in Octave Specialty Group in Q2 2013 and has held it in 48 quarters since.
  • Citadel Advisors's Octave Specialty Group position peaked at $9.65M in Q1 2025.
  • 148 funds tracked by Wall St. Rank held Octave Specialty Group as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.